Xu Yuan Insider Trades

Insider Trading History

Track insider trading activity for Xu Yuan. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Fate Therapeutics
Fate Therapeutics FATE
Director
Holding Value $190k 87,900 shares
Last Trade
Jun 12, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$181k 87,900 shares
$2.06
$2.16
Xilio Therapeutics
Xilio Therapeutics XLO
Director
Holding Value $44.5k 5,000 shares
Last Trade
Jun 11, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$40k 5,000 shares
$7.99
$8.90
Akero Therapeutics
Akero Therapeutics AKRO
Director
Holding Value $0 0 shares
Last Trade
Dec 09, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$5.71M 104,398 shares
$54.65
$54.65
Xilio Therapeutics
Xilio Therapeutics XLO
Director
Holding Value $276k 31,000 shares
Last Trade
Jun 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$21.4k 31,000 shares
$0.69
$8.90
Akero Therapeutics
Akero Therapeutics AKRO
Director
Holding Value $514k 9,398 shares
Last Trade
Jun 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$485k 9,398 shares
$51.61
$54.65
Fate Therapeutics
Fate Therapeutics FATE
Director
Holding Value $119k 55,000 shares
Last Trade
May 29, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$72.6k 55,000 shares
$1.32
$2.16
Fate Therapeutics
Fate Therapeutics FATE
Director
Holding Value $18.7k 8,669 shares
Last Trade
Aug 06, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.68k 633 shares
$4.23
$2.16
Xilio Therapeutics
Xilio Therapeutics XLO
Director
Holding Value $223k 25,000 shares
Last Trade
Jun 14, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$25.5k 25,000 shares
$1.02
$8.90
Akero Therapeutics
Akero Therapeutics AKRO
Director
Holding Value $1.42M 26,000 shares
Last Trade
Jun 08, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$599k 26,000 shares
$23.02
$54.65
Fate Therapeutics
Fate Therapeutics FATE
Director
Holding Value $86.4k 40,000 shares
Last Trade
Jun 07, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$147k 40,000 shares
$3.68
$2.16
Fate Therapeutics
Fate Therapeutics FATE
Director
Holding Value $20.1k 9,302 shares
Last Trade
Aug 04, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.34k 632 shares
$3.71
$2.16
Akero Therapeutics
Akero Therapeutics AKRO
Director
Holding Value $820k 15,000 shares
Last Trade
Jun 23, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$762k 15,000 shares
$50.83
$54.65
Fate Therapeutics
Fate Therapeutics FATE
Director
Holding Value $21.5k 9,934 shares
Last Trade
Jun 14, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$19.3k 3,460 shares
$5.58
$2.16
Xilio Therapeutics
Xilio Therapeutics XLO
Director
Holding Value $117k 13,200 shares
Last Trade
Jun 12, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$37k 13,200 shares
$2.80
$8.90
Fate Therapeutics
Fate Therapeutics FATE
Director
Holding Value $86.4k 40,000 shares
Last Trade
Jun 06, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$221k 40,000 shares
$5.52
$2.16
Xilio Therapeutics
Xilio Therapeutics XLO
Director
Holding Value $117k 13,200 shares
Last Trade
Jun 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$30.1k 13,200 shares
$2.28
$8.90
Fate Therapeutics
Fate Therapeutics FATE
Director
Holding Value $28.9k 13,394 shares
Last Trade
Jun 09, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$203k 8,650 shares
$23.48
$2.16
Akero Therapeutics
Akero Therapeutics AKRO
Director
Holding Value $820k 15,000 shares
Last Trade
Jun 02, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$122k 15,000 shares
$8.13
$54.65
Xilio Therapeutics
Xilio Therapeutics XLO
Director
Holding Value $235k 26,400 shares
Last Trade
Jan 04, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$420k 26,400 shares
$15.92
$8.90
Fate Therapeutics
Fate Therapeutics FATE
Director
Holding Value $16.2k 7,501 shares
Last Trade
Aug 03, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.02M 12,245 shares
$83.25
$2.16

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up